Latest News

Scientists awarded £5.7m to harness epigenetics in next-generation anti-viral therapies

BCI researcher Dr Gabriella Ficz and team have been awarded funding as part of a £5.7m national collaborative initiative exploring how epigenetics can be harnessed to strengthen our immune system’s ability to fight viruses. Dr Ficz will receive £880,000 to support her team’s contribution to the epiPRIME project, awarded by the Advanced Research and Invention Agency (ARIA).

Professor Louise Jones elected Fellow of the Academy of Medical Sciences

Professor Louise Jones at Barts Cancer Institute, Queen Mary University of London, has been elected to the Academy of Medical Sciences. She joins 60 exceptional biomedical and health scientists elected to its prestigious Fellowship.

Barts Cancer Institute teams awarded nearly £3m from Cancer Research UK to seek novel cancer therapy targets

Pancreatic Cancer Research Fund Tissue Bank achieves landmark international accreditation

The Pancreatic Cancer Research Fund Tissue Bank (PCRFTB) has become the first in England to receive ISO 20387:2018 accreditation, an international standard that recognises excellence in biobanking.

£10m awarded to partnership investigating innovative radiolabelled nanomedicines

Researchers at Barts Cancer Institute (BCI), Queen Mary University of London, will play a part in a revolutionary new partnership with King’s College London and the University of Leeds, aiming to accelerate and optimise the clinical translation of healthcare nanotechnologies.

Barts Cancer Institute receives LEAF Awards for sustainability

The Barts Cancer Institute (BCI), Queen Mary University of London, has been awarded the LEAF Bronze award for sustainability, achieving Bronze or Silver certification standards across each of our 15 laboratory sections.

Queen Mary’s Barts Cancer Institute co-leads £43.6m initiative to accelerate AI-powered cancer breakthroughs

Barts Cancer Institute, Queen Mary University of London will co-lead a ground-breaking collaboration, PharosAI, that aims to harness cutting-edge artificial intelligence (AI) and unlock decades of NHS cancer data. The UK government is committing £18.9 million to the project.

Professor Louise Jones wins Goudie Medal for excellence in pathology

Professor Louise Jones has been awarded the Pathological Society’s prestigious Goudie Medal for her seminal contributions to pathological science and understanding of disease.

Professor Sarah McClelland awarded £1.5m from CRUK to study cancer’s chromosomal chaos

Congratulations to Professor Sarah McClelland, who has received a £1,500,000 Programme Foundation Award from Cancer Research UK (CRUK), to support her lab’s work at Barts Cancer Institute (BCI), Queen Mary University of London.

€9.8m ERC Synergy grant awarded to study how human tissues stay healthy as we age

Researchers at the BCI and the Crick have been awarded a €9.8m ERC Synergy grant for their pioneering 6-year project called MUTAHOME.

BCI paves the way for the next era of radiation research in £18m partnership

The BCI is advancing radiation research through the Cancer Reserach UK City of London Radiation Research Centre of Excellence, an £18M partnership with the Crick, UCL and King's.

BCI part of new UK-wide cancer immunotherapy initiative

Researchers from Barts Cancer Institute, Queen Mary University of London are part of a nationwide team of universities, hospitals and industry collaborating on a new platform to understand immunotherapy response and side effects in cancer.

Professor John Gribben receives prestigious José Carreras award

Professor Fran Balkwill elected as Fellow of the Royal Society

Professor Fran Balkwill is one of 90 exceptional researchers across the world to be elected this year to the Fellowship of the Royal Society, the UK’s national academy of sciences.

Dr Luigi Ombrato awarded Cancer Research UK grant to understand how the seeds of secondary tumours grow

Congratulations to Dr Luigi Ombrato who has been awarded a £700k grant to investigate the earliest stages of cancer spread.

New Epigenetics Hub set to advance early disease detection

A £3m collaboration will investigate how marks on DNA in blood enable early disease detection

Dr Mirjana Efremova awarded £1m Cancer Research UK grant to decode bowel cancer’s plastic nature

Congratulations to Dr Mirjana Efremova who has been awarded a £1m grant to use cutting-edge computational tools to study how bowel cancer adapts.

BCI researchers part of international team shortlisted for Cancer Grand Challenges award

Dr Özgen Deniz and Dr Benjamin Werner are part of a team shortlisted for these prestigious awards